🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objective of the study objectives was to explore survival advantage for an ...
Status
Terminated
Location
Institut Gustave Roussy
Start Date
1995-07
Trial ID
NCT00162695
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Krankenanstalten Gilead gCmbH Neurochirurgische Klinik
Start Date
2010-10
Trial ID
NCT01228331
Older patients with acute myeloid leukemia (AML) have a small (\< 10%) chan...
Status
Unknown
Location
UZ Antwerpen
Start Date
2014-11-28
Trial ID
NCT02172872
Treatments Being Tested
The purpose of this study is to demonstrate that treatment with BMS-986012 ...
Status
Completed
Location
Local Institution - 0075
Start Date
2021-03-17
Trial ID
NCT04702880
Treatments Being Tested
RATIONALE: Biological therapies, such as cellular adoptive immunotherapy, s...
Status
Completed
Location
Fred Hutchinson Cancer Research Center
Start Date
1998-12
Trial ID
NCT00107354
Central nervous system (CNS) relapses of aggressive lymphomas are a rare bu...
Status
Unknown
Location
Charité Universitätsmedizin
Start Date
2007-10
Trial ID
NCT01148173
Treatments Being Tested
Ph-like ALL is a recently recognized high-risk subgroup and the optimal the...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564470
The purpose of this study is to evaluate the safety and efficacy of Melphal...
Status
Unknown
Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Start Date
2018-01-02
Trial ID
NCT03385096
Treatments Being Tested
The goal of this clinical trial is to investigate the efficacy, safety and ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09-30
Trial ID
NCT06620796
Treatments Being Tested
The purpose of the study is to determine whether the addition of Ipilimumab...
Status
Completed
Location
Genesis Cancer Center
Start Date
2011-12-13
Trial ID
NCT01450761
Treatments Being Tested